BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan Y, Xiang C, Yang Z, Miao D, Zhang D. Rho Kinase Inhibition by Fasudil Attenuates Adriamycin-Induced Chronic Heart Injury. Cardiovasc Toxicol 2020;20:351-60. [PMID: 31894538 DOI: 10.1007/s12012-019-09561-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Mauro AG, Mezzaroma E, Toldo S, Melendez GC, Franco RL, Lesnefsky EJ, Abbate A, Hundley WG, Salloum FN. NLRP3-mediated inflammation in cardio-oncology: sterile yet harmful. Transl Res 2023;252:9-20. [PMID: 35948198 DOI: 10.1016/j.trsl.2022.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xiang C, Zhu Y, Xu M, Zhang D. Fasudil Ameliorates Osteoporosis Following Myocardial Infarction by Regulating Cardiac Calcitonin Secretion. J Cardiovasc Transl Res 2022;15:1352-65. [PMID: 35551627 DOI: 10.1007/s12265-022-10271-8] [Reference Citation Analysis]
3 Deng Z, Yao J, Xiao N, Han Y, Wu X, Ci C, Chen K, Geng X. DNA methyltransferase 1 (DNMT1) suppresses mitophagy and aggravates heart failure via the microRNA-152-3p/ETS1/RhoH axis. Lab Invest 2022;102:782-93. [PMID: 35149775 DOI: 10.1038/s41374-022-00740-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Montagnoli TL, da Silva JS, Sudo SZ, Santos AD, Gomide GF, de Sá MPL, Zapata-Sudo G. ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension. Cells 2021;10. [PMID: 34209333 DOI: 10.3390/cells10071648] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
5 Jianjun Z, Baochun Z, Limei M, Lijun L. Exploring the beneficial role of ROCK inhibitors in sepsis-induced cerebral and cognitive injury in rats. Fundam Clin Pharmacol 2021;35:882-91. [PMID: 33440039 DOI: 10.1111/fcp.12645] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
6 Xiang C, Yan Y, Zhang D. Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro. J Pharmacol Sci 2021;145:6-15. [PMID: 33357780 DOI: 10.1016/j.jphs.2020.10.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
7 Afzal M. Recent updates on novel therapeutic targets of cardiovascular diseases. Mol Cell Biochem 2021;476:145-55. [PMID: 32845435 DOI: 10.1007/s11010-020-03891-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]